The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Open accessPublished version of a preprint
Abstract
Cellular senescence suppresses cancer by irreversibly arresting cell proliferation. Senescent cells acquire a proinflammatory senescence-associated secretory phenotype. Many genotoxic chemotherapies target proliferating cells nonspecifically, often with adverse reactions. In accord with prior work, we show that several chemotherapeutic drugs induce senescence of primary murine and human cells. Using a transgenic mouse that permits tracking and eliminating senescent cells, we show that therapy-induced senescent (TIS) cells persist and contribute to local and systemic inflammation. Eliminating TIS cells reduced several short- and long-term effects of the drugs, including bone marrow suppression, cardiac dysfunction, cancer recurrence, and physical activity and strength. Consistent with our findings in mice, the risk of chemotherapy-induced fatigue was significantly greater in humans with increased expression of a senescence marker in T cells prior to chemotherapy. These findings suggest that senescent cells can cause certain chemotherapy side effects, providing a new target to reduce the toxicity of anticancer treatments. Significance: Many genotoxic chemotherapies have debilitating side effects and also induce cellular senescence in normal tissues. The senescent cells remain chronically present where they can promote local and systemic inflammation that causes or exacerbates many side effects of the chemotherapy. Cancer Discov; 7(2); 165–76. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 115
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, through SASP, senescent cells contribute to cancer development162,163 and metastasis164, treatment failure and increased risk of recurrence165.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [165]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SASP can also explain chemotherapy side effects, such as bone marrow suppression, cardiac dysfunction, blood clotting, or cancer relapse (Demaria et al. 2017; Wiley et al. 2019).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Demaria et al, 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence, a central hallmark of aging,13,14 encompasses heterogeneous cellular states triggered by prolonged cell stress resulting in the irreversible arrest of proliferation and permanent changes to cell function in vivo.15,16,17,18,19”
From Uncovering the signatures of aging and senescence in the human dorsolateral prefrontal cortex (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these detrimental effects were neutralized via genetic or pharmacological clearance of senescent cells 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mouse models have demonstrated that TIS promotes cardiac dysfunction, inflammation, bone loss, muscle weakness, renal and hepatic failure, haematopoietic insufficiency, and overall frailty 27,111,202 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with cancer, older age (>65 years) is associated with reduced tolerance to anticancer treatment 27 and a greater risk of developing serious AEs 192 , as well as genetic alterations that might lead to reduced sensitivity to treatment; together these features constitute major hurdles for the successful administration of antineoplastic therapies at efficient doses.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Therapy-induced senescence plays an important role in determining the outcome of anti-cancer treatment 40, whilst also being responsible for some of its side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“These include increases in local and systemic inflammation and cancer reoccurrence (Demaria et al. 2017).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Demaria et al. 2017
The cited source says what the claim attributes to it.
In the citing paper
“In some cases, these triggers cause fibroblasts to enter a non-proliferative state termed ‘senescence’71, which is distinct from the phenotype of an aged fibroblast.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [71]
The cited source says what the claim attributes to it.
In the citing paper
“For example, DOX-induced systemic senescence was found to promote metastasis in an orthotopic mouse model of breast cancer.”
From Drug repurposing for cancer therapy (2024) · cites this paper as [232]
The cited source says what the claim attributes to it.
In the citing paper
“p16 INK4a expression is considered a common and robust, albeit not necessarily specific, marker of senescence, and its promoter activity and transcriptional activation are extensively exploited as reporters of senescent cells invivo 20,23,27,28 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Alkylating agents 27,95,96 (for example, cisplatin, cyclophosphamide and temozolomide), topoisomerase inhibitors 27,65,91,95 (such as doxorubicin, etoposide and camptothecin) and γ- irradiation 78 , but also microtubule inhibitors 27,97,98 (for example, paclitaxel) and, to a lesser extent, vinca alkaloids 78 (for example, vincristine), have all been identified as senescence inducers in preclinical”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“In tumour- free mice, exposure to the topoisomerase II inhibitor doxorubicin leads to systemically elevated SASP and functional impairment reminiscent of accelerated ageing, which is only explained in part by direct organ toxicity of this chemotherapeutic agent 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Doxorubicin- induced systemic senescence contributed to breast cancer metastasis in an orthotopic mouse model.”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, high expression of p16 INK4a in circulating Tcells before treatment, presumably a surrogate biomarker of system-wide senescent cell burden, correlates with severe chemotherapy- induced fatigue in patients with breast cancer, suggesting that senescent cells might contribute to the reduced tolerance of older individuals to anticancer therapies 27 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [27]
In the citing paper
“SASP also mediates the harmful effects of senescent cells which accumulate upon chemotherapy treatment as their chronic presence promotes local and systemic inflammation.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“age-related or therapy-induced senescent cells are mainly linked with secretion of inflammatory factors (Baker et al., 2016; Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Elimination of therapy-induced senescent cells can prevent cancer recurrence (Demaria et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Demaria et al., 2017
In the citing paper
“Moreover, senescent cells have been implicated in the adverse effects of some chemotherapeutic regimens as well as in the recurrence of specific neoplasms, at least in mice [969].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [969]
In the citing paper
“whilst also contributing to their side effects 41.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [41]
In the citing paper
“Via the SASP, senescent cells contribute to multiple chronic health conditions associated with inflammaging, e.g., atherosclerosis (16), osteoarthritis (17), cancer (18), myeloid skewing in the bone marrow (19), pulmonary fibrosis (20), Alzheimer’s disease and Parkinson’s disease (21–23), and insulin resistance (24).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [18]
In the citing paper
“These persisting senescent cells have been recently tied to multiple chronic diseases other than atherosclerosis, including diabetes mellitus,85 obesity,85 Alzheimer’s disease,86 heart failure,10,87 idiopathic pulmonary fibrosis,88,89 chronic obstructive pulmonary disease,90 chronic kidney disease,91 cancer,92 and osteoarthritis.93”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“However, chronic senescence promotes cancer.92”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [92]
In the citing paper
“and paradoxically tumorigenesis (Demaria et al., 2017).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Demaria et al., 2017
In the citing paper
“However, senescence may contribute to reduced patient resilience to cancer therapies”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [67]
In the citing paper
“The use of senotherapeutic drugs could potentially be effective in treating a variety of conditions primarily or secondarily mediated by accumulation of senescent cells [6, 33, 67–87].”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [69]
In the citing paper
“The development of a tumor cell population that escapes from senescence and restarts proliferating may contribute to cancer relapse [342].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [342]
In the citing paper
“Senescent cells have also been postulated to mediate resistance to therapy, while contributing to off-target systemic effects and cancer relapse linked to the treatment with standard anticancer regimens.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“In the same model, whole-body clearance of p16 + cells generated by doxorubicin treatment reduces signs of systemic frailty and limits tumor recurrence.200”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [200]
In the citing paper
“Indeed, persistent senescent cells may contribute to detrimental short and long-term side effects of treatment, as well as to metastases and relapse (Demaria et al., 2017).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Demaria et al., 2017
In the citing paper
“the elimination of therapy-induced senescent cells reduced several side-effects of chemotherapy and even cancer recurrence in mice14.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [14]
In the citing paper
“Furthermore, ablation of senescent cells after chemotherapy can prevent or delay cancer relapse and spread to distal tissues.59”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“Moreover, senescent cells accumulate with age in several vertebrate organisms (1), and their elimination can delay the onset of several age-associated disorders in mice (3, 4).”
BackgroundInfluentialSelf-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationDoxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,870
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y. G., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,842
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Self-citationInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,000
Telomeres, Aging and Exercise: Guilty by Association?
Chilton, W., O’Brien, B. J., & Charchar, F. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122573 · Cited by 44
Elimination of p19ARF‐expressing cells protects against pulmonary emphysema in mice
Mikawa, R., Suzuki, Y., Baskoro, H., Kanayama, K., Sugimoto, K., Sato, T., & Sugimoto, M. (2018) · Aging Cell · doi:10.1111/acel.12827 · Cited by 44
Feng, M., Kim, J., Field, K. P., Reid, C., Chatzistamou, I., & Shim, M. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00041 · Cited by 44
Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging
Rossi, M. S., & Gorospe, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.010 · Cited by 44
Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
Clayton, Z. S., Hutton, D. A., Mahoney, S. A., & Seals, D. R. (2021) · Aging and Cancer · doi:10.1002/aac2.12033 · Cited by 44
Liu, P., Zhang, B., Li, Y., & Yuan, Q. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00842-7 · Cited by 43
Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Wirsdörfer, F., & Jendrossek, V. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0865-1 · Cited by 43
Inflammatory signaling in genomically instable cancers
Talens, F., & van Vugt, M. A. T. M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638192 · Cited by 43
Rosas‐González, V. C., Téllez‐Bañuelos, M. C., Hernández‐Flores, G., Bravo‐Cuéllar, A., Aguilar‐Lemarroy, A., Jave‐Suárez, L. F., Haramati, J., Ibarra, F. S., & Ortiz‐Lazareno, P. C. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12559 · Cited by 43
Murray, D. L., & Mirzayans, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165766 · Cited by 43
The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence
Shafqat, S., Arana‐Chicas, E., Shafqat, A., & Hashmi, S. K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158452 · Cited by 43
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors
Granieri, L., Marocchi, F., Melixetian, M. B., Mohammadi, N., Nicoli, P., Cuomo, A., Bonaldi, T., Confalonieri, S., Pisati, F., Giardina, G., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111396 · Cited by 43
To stay young, kill zombie cells
Scudellari, M. (2017) · Nature · doi:10.1038/550448a · Cited by 43
Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer
Zhou, L., Niu, Z., Wang, Y., Zheng, Y. Y., Zhu, Y., Wang, C., Gao, X., Gao, L., Zhang, W., Zhang, K., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-021-00769-6 · Cited by 42
Effects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 42
Cellular senescence promotes cancer metastasis by enhancing soluble E-cadherin production
Kawaguchi, K., Komoda, K., Mikawa, R., Asai, A., & Sugimoto, M. (2021) · iScience · doi:10.1016/j.isci.2021.103022 · Cited by 42
Application of Gold Nanoparticle-Based Materials in Cancer Therapy and Diagnostics
Vodyashkin, A. A., Rizk, M. G. H., Kezimana, P., Kirichuk, A. A., & Stanishevskiy, Y. (2021) · ChemEngineering · doi:10.3390/chemengineering5040069 · Cited by 42
Sreekumar, P. G., Reddy, S. T., Hinton, D. R., & Kannan, R. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108918 · Cited by 42
Morales-Valencia, J., Lau, L., Martí-Nin, T., Özerdem, U., & David, G. (2022) · Oncogene · doi:10.1038/s41388-022-02433-4 · Cited by 42
Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy
Liu, Y., & Chen, Q. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00141-0 · Cited by 41
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 41
Changes in the mammary gland during aging and its links with breast diseases
Lin, J., Ye, S., Hao, K., Lin, L., Wu, X., Guo, M., Jiao, B., Chen, C., & Zhao, L. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023073 · Cited by 41
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
Malayaperumal, S., Marotta, F., Kumar, M. M., Somasundaram, I., Ayala, A., Pinto, M. F. M., Banerjee, A., & Pathak, S. (2023) · Clinics and Practice · doi:10.3390/clinpract13040076 · Cited by 41
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia
Englund, D. A., Jolliffe, A. M., Hanson, G. J., Aversa, Z., Zhang, X., Jiang, X., White, T. A., Zhang, L. J., Monroe, D. G., Robbins, P. D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.169512 · Cited by 41
Emerging Roles of Vitamin B12 in Aging and Inflammation
Simonenko, S. Y., Bogdanova, D. A., & Kuldyushev, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095044 · Cited by 41
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation
Mongiardi, M. P., Radice, G., Piras, M., Stagni, V., Pacioni, S., Re, A., Putti, S., Ferrè, F., Farsetti, A., Pallini, R., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0798-2 · Cited by 41
Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence
Putavet, D. A., & de Keizer, P. L. J. (2021) · Cancers · doi:10.3390/cancers13071560 · Cited by 41
Franzin, R., Stasi, A., Ranieri, E., Netti, G. S., Cantaluppi, V., Gesualdo, L., Stallone, G., & Castellano, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630419 · Cited by 41
Palicelli, A., Croci, S., Bisagni, A., Zanetti, E., de Biase, D., Melli, B., Sanguedolce, F., Ragazzi, M., Zanelli, M., Chaux, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212330 · Cited by 41
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz‐Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 41
Han, X., Yuan, T., Zhang, J., Shi, Y., Li, D., Dong, Y., & Fan, S. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17333 · Cited by 41
Estepa‐Fernández, A., García‐Fernández, A., Lérida‐Viso, A., Blandez, J. F., Galiana, I., Sancenón, F., Orzáez, M., & Martínez‐Máñez, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106628 · Cited by 41
El‐Far, A. H., Godugu, K., Noreldin, A. E., Saddiq, A. A., Almaghrabi, O. A., Jaouni, S. K. A., & Mousa, S. A. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211035450 · Cited by 40
Cellular senescence offers distinct immunological vulnerabilities in cancer
Zhou, L., Ma, B., & Ruscetti, M. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.010 · Cited by 40
Hou, J., Jeon, B.-M., Yun, Y. J., Cui, C.-H., & Kim, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051244 · Cited by 40
Narayan, V., Harrison, M. R., Cheng, H. H., Kenfield, S. A., Aggarwal, R. R., Kwon, D. H.-M., McKay, R. R., Hauger, R. L., Hart, N. H., Conzen, S. D., et al. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.10.006 · Cited by 40
Clayton, Z. S., Brunt, V. E., Hutton, D. A., Casso, A. G., Ziemba, B. P., Melov, S., Campisi, J., & Seals, D. R. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16759 · Cited by 40
Self-citationDehkordi, M. F., Farhadian, S., Abdolvand, M. A., Soureshjani, E. H., Rahmani, B., & Darzi, S. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.117373 · Cited by 40
Hu, L., Dong, C., Wang, Z., He, S., Yang, Y., Zi, M., Li, H., Zhang, Y., Chen, C., Zheng, R., et al. (2023) · Aging Cell · doi:10.1111/acel.13896 · Cited by 39
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Subedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., Gupta, G., MacLoughlin, R. J., Oliver, B. G. G., Dua, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102813 · Cited by 39
Autophagy Governs Protumorigenic Effects of Mitotic Slippage–induced Senescence
Jakhar, R., Luijten, M., Wong, A. X. F., Cheng, B., Guo, K., Neo, S. P., Au, B. V., Kulkarni, M., Lim, K. J., Maimaiti, J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0024 · Cited by 39
The mTORC1-autophagy pathway is a target for senescent cell elimination
Kucheryavenko, O., Nelson, G., von Zglinicki, T., Korolchuk, V. I., & Carroll, B. (2019) · Biogerontology · doi:10.1007/s10522-019-09802-9 · Cited by 39
Lee, Y., Chen, Y.-Y., Yeh, Y.-L., Wang, Y., & Chen, R.-J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112716 · Cited by 39
Stereotactic Lung Irradiation in Mice Promotes Long-Term Senescence and Lung Injury
Soysouvanh, F., Benadjaoud, M. A., Santos, M. D., Mondini, M., Lavigne, J., Bertho, A., Buard, V., Tarlet, G., Adnot, S., Deutsch, É., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.12.039 · Cited by 39
Saleh, T., Alhesa, A., Al-Balas, M., Abuelaish, O. M., Mansour, A. T., Awad, H., El‐Sadoni, M., Carpenter, V. J., & Azab, B. (2021) · Bioscience Reports · doi:10.1042/bsr20210079 · Cited by 39
Emerging Prodrug-Engineered nanomedicines for synergistic Chemo-Phototherapy
Shan, X., Zhao, Z., Wang, C., Sun, J., He, Z., Luo, C., & Zhang, S. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136383 · Cited by 39
Prognostic implications of cellular senescence in resected non-small cell lung cancer
Domen, A., Deben, C., Pauw, I. D., Hermans, C., Lambrechts, H. A. J., Verswyvel, J., Siozopoulou, V., Pauwels, P., Demaria, M., van de Wiel, M., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-192 · Cited by 39
Self-citationSenescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 39
Li, W., Kawaguchi, K., Tanaka, S., He, C., Maeshima, Y., Suzuki, E., & Toi, M. (2023) · Communications Biology · doi:10.1038/s42003-023-05433-6 · Cited by 38
Riviere-Cazaux, C., Carlstrom, L. P., Neth, B. J., Olson, I., Rajani, K. R., Rahman, M., Ikram, S., Mansour, M. A., Mukherjee, B., Warrington, A. E., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00476-8 · Cited by 38
Targeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 38
Connecting cancer relapse with senescence
Pluquet, O., Abbadie, C., & Coqueret, O. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.004 · Cited by 38
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 38
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário‐Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 38
Converging Paths of Pulmonary Arterial Hypertension and Cellular Senescence
van der Feen, D. E., Berger, R. M. F., & Bartelds, B. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0329tr · Cited by 38
Wang, S., Jurdi, N. E., Thyagarajan, B., Prizment, A. E., & Blaes, A. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063319 · Cited by 37
Shaaban, S., Althikrallah, H. A., Negm, A., Elmaaty, A. A., & Al-Karmalawy, A. A. (2024) · RSC Advances · doi:10.1039/d4ra02944e · Cited by 37
Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers
Leng, F., Liu, F., Yang, Y., Wu, Y., & Tian, W. (2018) · Nanomaterials · doi:10.3390/nano8040202 · Cited by 37
Sublethal whole-body irradiation causes progressive premature frailty in mice
Fielder, E., Weigand, M., Agneessens, J., Griffin, B., Parker, C., Miwa, S., & von Zglinicki, T. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.006 · Cited by 37
Cheng, T., Zhang, Z., Shen, H., Jian, Z., Li, J., Chen, Y., Shen, Y., & Dai, X. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00687-2 · Cited by 37
Glutamine promotes escape from therapy-induced senescence in tumor cells
Pacifico, F., Badolati, N., Mellone, S., Stornaiuolo, M., Leonardi, A., & Crescenzi, E. (2021) · Aging · doi:10.18632/aging.203495 · Cited by 37
Hong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 37
Wang, C., Long, Q., Fu, Q., Xu, Q., Fu, D., Li, Y., Gao, L., Guo, J., Zhang, X., Lam, E. W. ‐., et al. (2021) · Oncogene · doi:10.1038/s41388-022-02476-7 · Cited by 37
Self-citationImpacts of gut microbiota alteration on age-related chronic liver diseases
Adhikary, S., Esmeeta, A., Dey, A., Banerjee, A., Saha, B., Gopan, P., Duttaroy, A. K., & Pathak, S. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.017 · Cited by 36
Zhang, H., Gui, T., Liu, R., Tong, K., Wu, C., Li, Z., Huang, X., Xu, Q., Yang, J., Tang, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03416-1 · Cited by 36
Age‐associated expression of p21and p53 during human wound healing
Chia, C. W., Sherman‐Baust, C. A., Larson, S. A., Pandey, R., Withers, R., Karikkineth, A. C., Zukley, L. M., Campisi, J., Egan, J. M., Sen, R., et al. (2021) · Aging Cell · doi:10.1111/acel.13354 · Cited by 36
Self-citationAutophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 36
Soto-Gamez, A., Wang, Y., Zhou, X., Seras, L., Quax, W. J., & Demaria, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.038 · Cited by 36
Self-citationSenescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
Ni, S., Liu, Q., Chen, X., Ding, L., Cai, L., Mao, F., Shi, D., Hoffman, R. M., Li, J., & Jia, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01128-2 · Cited by 35
Senolytic treatment alleviates doxorubicin‐induced chemobrain
Budamagunta, V., Kumar, A., Rani, A., Sindhu, S. M., Yang, Y., Zhou, D., & Foster, T. C. (2024) · Aging Cell · doi:10.1111/acel.14037 · Cited by 35
Self-citationBalasubramanian, P., Kiss, T., Gulej, R., Toth, A. N., Tarantini, S., Yabluchanskiy, A., Ungvari, Z. I., & Csiszár, A. (2024) · Nutrients · doi:10.3390/nu16070952 · Cited by 35
Senolytics: charting a new course or enhancing existing anti-tumor therapies?
Czajkowski, K., Herbet, M., Murias, M., & Piątkowska‐Chmiel, I. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01018-5 · Cited by 35
Stoddart, A., Wang, J., Fernald, A. A., Davis, E. M., Johnson, C. R., Hu, C., Cheng, J. X., McNerney, M. E., & Beau, M. M. L. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-19-0028 · Cited by 35
Measuring Biologic Resilience in Older Cancer Survivors
Sedrak, M. S., Gilmore, N. J., Carroll, J. E., Muss, H. B., Cohen, H. J., & Dale, W. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00245 · Cited by 35
Self-citationMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 35
Kaur, J., Adhikari, M., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., Stambough, J. B., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0857 · Cited by 34
Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity
Karschnia, P., Nelson, T. A., & Dietrich, J. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00863-2 · Cited by 34
Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
Hellmich, C., Moore, J. A., Bowles, K. M., & Rushworth, S. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00230 · Cited by 34
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Sfera, A., Osorio, C. P., del Campo, C. M. Z.-M., Pereida, S., Maurer, S., Maldonado, J. C., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673217 · Cited by 34
NGAL as a Potential Target in Tumor Microenvironment
Crescenzi, E., Leonardi, A., & Pacifico, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212333 · Cited by 34
The Intricate Interplay between Cell Cycle Regulators and Autophagy in Cancer
Ziegler, D. V., Huber, K., & Fajas, L. (2021) · Cancers · doi:10.3390/cancers14010153 · Cited by 34
Chaturvedi, P., George, V., Shrestha, N., Wang, M., Dee, M. J., Zhu, X., Liu, B., Egan, J. O., D’Eramo, F., Spanoudis, C. M., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.025 · Cited by 34
Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer
Ring, A., Spataro, M., WICKI, A. N., & Aceto, N. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.929893 · Cited by 34
Immunomodulatory effects of CDK4/6 inhibitors
Zhang, S., Xu, Q., Sun, W., Zhou, J., & Zhou, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188912 · Cited by 34
Proton versus photon radiation–induced cell death in head and neck cancer cells
Wang, L., Han, S., Zhu, J., Wang, X., Li, Y., Wang, Z., Lin, E. Y., Wang, X., Molkentine, D. P., Blanchard, P., et al. (2018) · Head & Neck · doi:10.1002/hed.25357 · Cited by 34
Therapy-induced senescent tumor cells in cancer relapse
Song, K., Wang, J., & Huang, D. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.09.001 · Cited by 33
Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer
Menéndez, J. A., & Alarcón, T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00049 · Cited by 33
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 33
Martínez, J., Tarallo, D., Palma, L. M., Victoria, S., Bresque, M., Rodríguez-Bottero, S., Marmisolle, I., Escande, C., Cassina, P., Casanova, G., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190405 · Cited by 33
Bates, M., Furlong, F. M., Gallagher, M. F., Spillane, C. D., McCann, A. H., O’Toole, S. A., & O’Leary, J. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.005 · Cited by 33
Remodeling of the H3 nucleosomal landscape during mouse aging
Chen, Y., Bravo, J. I., Son, J. M., Lee, C. D., & Benayoun, B. A. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.12.003 · Cited by 33
Shachar, S. S., Deal, A. M., Reeder-Hayes, K. E., Nyrop, K. A., Mitin, N., Anders, C. K., Carey, L., Dees, E. C., Jolly, T. A., Kimmick, G. G., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa082 · Cited by 33
Self-citationPiperine: An Anticancer and Senostatic Drug
Lim, J. S., Lee, D. Y., Lim, J. H., Oh, W. K., Park, J. T., Park, S. C., & Cho, K. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2704137 · Cited by 33
Yang, Z., Li, Z., Zhao, Y., Zhao, Y., Li, X., He, L., Zvyagin, A. V., Yang, B., Lin, Q., & Ma, X. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c06890 · Cited by 33
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Contrasting characteristics of daily physical activity in older adults by cancer history
Wanigatunga, A. A., Gresham, G. K., Kuo, P., Martínez-Amezcua, P., Zipunnikov, V. M., Dy, S. M., Simonsick, E. M., Ferrucci, L., & Schrack, J. A. (2018) · Cancer · doi:10.1002/cncr.31745 · Cited by 33
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Mori, J., Elhussin, I. A., Brennen, W. N., Graham, M. K., Lotan, T. L., Yates, C. C., Marzo, A. M. D., Denmeade, S. R., Yegnasubramanian, S., Nelson, W. G., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00827-x · Cited by 32
Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancer
Ziegler, D. V., Parashar, K., & Fajas, L. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.002 · Cited by 32
Metadata
- Authors
- Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., Muss, H., & Campisi, J.
- Affiliations
- University Medical Center Groningen (NL)
- 1Buck Institute for Research on Aging, Novato, California.
- University of Arkansas for Medical Sciences (US)
- Buck Institute for Research on Aging (US)
- 4HealthSpan Diagnostics, Research Triangle Park, North Carolina.
- University of North Carolina at Chapel Hill (US)
- 6Department of Pathobiology, University of Utrecht, Utrecht, the Netherlands.
- Corresponding author
- Demaria, Marco
- Campisi, Judith
- ORCID
- Venue
- Cancer Discovery
- Published
- 2017-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 165-176
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC5296251
- OpenAlex
- W2561396377
- Cited by
- 1,338
- References
- 34
- Citations by year
- 2026: 113 · 2025: 153 · 2024: 164 · 2023: 176 · 2022: 198 · 2021: 152 · 2020: 159 · 2019: 105 · 2018: 79 · 2017: 38
- FWCI
- 59.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- UNC Libraries
- Funders
- American-Italian Cancer Foundation
- National Institutes of Health (5r01ag024379-15, AG009909, AG017242, AG041122)
- National Institute on Aging (R56AG009909, R01-AG024379, R37AG009909, P01AG041122, P01AG017242)
- National Cancer Institute (R01CA122023, R01CA166347, R01CA203023, R01CA163896, P30CA016086)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- cellular senescence, therapy-induced senescence, chemotherapy toxicity, senescence-associated secretory phenotype, senolytics, senescent cell elimination, inflammation, tumor recurrence, myelosuppression, cardiotoxicity, chemotherapy-induced fatigue, T cells, genotoxic chemotherapy, transgenic mouse model
- MeSH terms
- Animals, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Mice, Transgenic, Neoplasm Recurrence, Local, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
